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During EVAR: A Prospective Analysis of Stentgrafts
With Suprarenal Fixation
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Objectives: The use of Palmaz stent for type I en-
doleaks during endovascular aneurysm repair (EVAR) in
patients with complex aortic neck (AN) morphology is
associated with increased morbidity. This study evaluates
the use of Palmaz stents during EVAR using stentgrafts
(SG) with supra-renal fixation in patients with complex AN
morphology.
Methods:Two hundred consecutive patients undergo-
ing EVAR using SG with suprarenal fixation (Talent: n 
100, and Zenith: n 100) were evaluated. During EVAR,
persistent type I endoleaks were treated by placement of a
Palmaz stent. All CTA images were analyzed for AN mor-
phology including neck length, diameter, angulations, and
thrombus. Data was prospectively entered into a vascular
registry and analysis included medical risk factors, AN
morphology, the need for Palmaz stent for type I en-
doleaks, and postoperative morbidity and mortality.
Results: Of the 200 EVAR, patients with the Talent
(n  100) and the Zenith (n  100) SG had comparable
demographics, and AAA size. The AN morphology was
also comparable between the Talent (T) and the Zenith (Z)
groups with respect to median AN length (T: 12.5mm,
Z:12.0mm), AN diameter (T: 27mm, Z: 29mm), AN
angulations (T: 12%60°, Z: 6%60°), and AN thrombus
3mm (T:18%, Z: 13%). Patients with the Talent stent-
graft had a significantly lower incidence of type I endoleaks
requiring Palmaz stents (9% vs 26%, p  0.05). Postopera-
tively, the incidence of type I (T: 3%, Z: 4%) and type II (T:
29% vs Z: 23%) endoleaks were similar between the groups.
Conversion to open repair was required in (3) 3% of Zenith
SG patients and none of the Talent SG patients. The 30-day
mortality in both groups was 0%.
Conclusions: AAA with complex and short AN length
can be treated successfully using the Talent and the Zenith
SG. However, in patients with comparable AN morphol-
ogy the incidence of type I endoleaks requiring Palmaz
stents is significantly greater when using the Zenith SG.
Author Disclosures: B. B. Chang: W. L. Gore & Associ-
ates, Medtronic, Cordis Endovascular, Abbott Vascular,
EV3, Aptus, Trivascular II, Cardiomems, Lemaitre, Lom-
bard, Research Grants; R. Darling: W. L. Gore & Associ-
ates, Medtronic, Cordis Endovascular, Abbott Vascular,
EV3, Aptus, Trivascular II, Cardiomems, Lemaitre, Lom-
bard, Research Grants WL Gore & Associates, Honorar-
ium; P. B. Kreienberg: W. L. Gore & Associates,
Medtronic, Cordis Endovascular, Abbott Vascular, EV3,
Aptus, Trivascular II, Cardiomems, Lemaitre, Lombard,Research Grants WL Gore & Associates, Honorarium
Sanofi Aventis, Speaker’s bureau; M. Mehta: W. L. Gore &
Associates, Medtronic, Cordis Endovascular, Abbott Vas-
cular, EV3, Aptus, Trivascular II, Cardiomems, Lemaitre,
Lombard, Research Grants W. L. Gore & Associates,
Medtronic, Cordis Endovascular, Abbott Vascular, EV3,
Aptus, Trivascular II, Cardiomems, Lemaitre, Lombard,
Honorarium W. L. Gore & Associates, Medtronic, Cordis
Endovascular, Abbott Vascular, EV3, Aptus, Trivascular II,
Cardiomems, Lemaitre, Speaker’s bureau; K. J. Ozsvath:
W. L. Gore & Associates, Medtronic, Cordis Endovascular,
Abbott Vascular, EV3, Aptus, Trivascular II, Cardiomems,
Lemaitre, Lombard, Research Grants WL Gore & Associ-
ates, Honorarium; P. Paty: W. L. Gore & Associates,
Medtronic, Cordis Endovascular, Abbott Vascular, EV3,
Aptus, Trivascular II, Cardiomems, Lemaitre, Lombard,
Research Grants; S. P. Roddy: W. L. Gore & Associates,
Medtronic, Cordis Endovascular, Abbott Vascular, EV3,
Aptus, Trivascular II, Cardiomems, Lemaitre, Lombard,
Research Grants WL Gore & Associates, Honorarium;
D. M. Shah: W. L. Gore & Associates, Medtronic, Cordis
Endovascular, Abbott Vascular, EV3, Aptus, Trivascular II,
Cardiomems, Lemaitre, Lombard, Research Grants; Y.
Sternbach: W. L. Gore & Associates, Medtronic, Cordis
Endovascular, Abbott Vascular, EV3, Aptus, Trivascular II,
Cardiomems, Lemaitre, Lombard, Research Grants WL
Gore & Associates, Honorarium; J. B. Taggert: W. L.
Gore & Associates, Medtronic, Cordis Endovascular, Ab-
bott Vascular, EV3, Aptus, Trivascular II, Cardiomems,
Lemaitre, Lombard, Research Grants.
RR8.
Long-term Results of Endovascular Repair of Para-
anastomotic Aneurysms After Previous Conventional
Aortic Prosthetic Reconstruction
Jan A. Ten Bosch1, Evert J. Waasdorp2, Joep A. Teijink3,
Jean-Paul M. de Vries4, Frans L. Moll2, Joost A. van
Herwaarden2. 1Vascular Surgery, Atrium Medical Center,
Heerlen, Netherlands; 2University Medical Center Utre-
cht, Utrecht, Netherlands; 3Catharina Hospital, Eind-
hoven, Netherlands; 4St. Antonius Hospital, Nieuwegein,
Netherlands
Objectives: Anastomotic pseudoaneurysms and true
paraanastomotic aneurysms (PAA) after initial abdominal
aortic prosthetic reconstruction often need reintervention,
since they are at risk for rupture. However, open surgical
reinterventions are technically challenging procedures with
highmortality andmorbidity rates. In the present study, we
describe the long-term clinical course in a large series of
patients with endovascular repair of PAAs.
Methods: A retrospective analysis of a prospective da-
tabase was performed. All patients treated with an endovas-
cular stentgraft between July 1999 and July 2009 for an
aorto-iliac PAA after previous aortic prosthetic reconstruc-
tion in one of the four participating centers, were included
